Plexiform neurofibromas

American Journal of Medical Genetics - Seminars in Medical Genetics

Volumn 89, Issue 1, 1999, Pages 31-37

  Korf, Bruce R ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

NF1; Plexiform neurofibroma

Indexed keywords

CANCER SURGERY; FOLLOW UP; HUMAN; NERVE SHEATH TUMOR; NEUROFIBROMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

HUMANS; MAGNETIC RESONANCE IMAGING; NEUROFIBROMA, PLEXIFORM; NEUROFIBROMATOSIS 1;

EID: 0033605480     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W     Document Type: Review

References (21)

1. Boltshauser E, Stocker H, Sailer H, Valavanis A. 1989. Intracranial abnormalities associated with facial plexiform neurofibromas in neurofibromatosis type 1. Neurofibromatosis 2: 274-277.
2. Britz G, Dailey AT, West GA, Kuntz C, Grant GA, Filler AG, Tsuruda JT. Goodkin R, Haynor DR, Maravilla K, Kliot M. 1995. Magnetic resonance imaging in the evaluation and treatment of peripheral nerve problems. Perspect Neurol Surg 6:53-68.
3. D'Agostino AN, Soule EH, Miller RH. 1963. Sarcomas of the peripheral nerves and somatic soft tissues associated with multiple neurofibromatosis (von Recklinghausen's disease). Cancer 16:1015-1027.
4. ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis. Cell 69:265-273.
5. Ducatman B, Scheithauer B Piepgras D, et al. 1986. Malignant peripheral nerve sheath tumors: a clinicopathological study of 120 cases. Cancer 57:2006-2021.
6. Dugoff L, Sujansky E. 1996. Neurofibromatosis type 1 and pregnancy. Am J Med Genet 66:7-10.
7. Ferguson VMG, Kyle PM. 1993. Orbital plexiform neurofibroma. Br J Ophthalmol 77: 527-528.
8. Filler AG, Kliot M, Howe FA, Hayes CE, Saunders DE, Goodkin R, Bell BA, Winn HR, Griffiths JR, Tsuruda JS. 1996. Application of magnetic resonance neurography in the evaluation of patients with peripheral nerve pathology. J Neurosurg 85:299-309.
9. Gibbs JB, Oliff A, Kohl NE. 1994. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 77:175-178.
10. Guha A, Lau N, Huvar I, et al. 1996. P levels are elevated in human NF1 peripheral nerve tumors. Oncogene 12:507-513.
11. Huson SM, Harper PS, Compston DAS. 1988. Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 111:1355-1381.
12. Jackson IT, Carbonnel A, Potparic Z, Shaw K. 1993. Orbitotemporal neurofibromatosis: classification and treatment. Plast Reconstr Surg 92:1-11.
13. Kirsch M, Strasser J, Allende R, Bello L, Zhang JMP. 1998. Angiostatin suppresses malignant glioma growth in vivo. Cancer Res 58:4654-4659.
14. Kjaer I, Keeling JW, Fischer H. 1997. Pattern of malformations in the axial skeleton in human trisomy 13 fetuses. Am J Med Genet 70:421-426.
15. Needle MN, Cnaan A, Dattilo J, et al. 1997. Prognostic signs in the surgical management of plexiform neurofibroma - The Children's Hospital of Philadelphia experience, 1974-1994. J Pediatr 131:678-682.
16. Polito E, Leccisotti A, Frezzotti R. 1993. Cosmetic possibilities and problems in eyelid neurofibromas. Ophthalmic Paediatrics & Genetics 14:43-50.
17. Riccardi VM. 1980. Pathophysiology of neurofibromatosis. V. Dermatologic insights into heterogeneity and pathogenesis. J Amer Acad Dermatol 3:157-166.
18. Schorry EK, Crawford AH, Egelhoff JC, Lovell AM, Saal HM. 1997. Thoracic tumors in children with neurofibromatosis-1. Am J Med Genet 74:533-537.
19. Tonsgard JH, Short MP, Kwak S, Dachman A. 1996. Computed tomographic imaging in neurofibromatosis. Ann Neurol 40:278.
20. Xu G, O'Connell P, Viskochil D, et al. 1990. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599-608.
21. Yan N, Ricca C, Fletcher J, Glover T, Seizinger BR, Manne V. 1995. Farnesyltransferase inhibitors block the neurofibromatosis type 1 (NF1) malignant phenotype. Cancer Res 55:3569-3575.